Correlation
The correlation between DLB and QGEN is 0.49, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
DLB vs. QGEN
Compare and contrast key facts about Dolby Laboratories, Inc. (DLB) and Qiagen N.V. (QGEN).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: DLB or QGEN.
Performance
DLB vs. QGEN - Performance Comparison
Loading data...
Key characteristics
DLB:
-0.17
QGEN:
0.22
DLB:
-0.05
QGEN:
0.47
DLB:
0.99
QGEN:
1.05
DLB:
-0.15
QGEN:
0.14
DLB:
-0.56
QGEN:
0.50
DLB:
8.63%
QGEN:
9.63%
DLB:
28.85%
QGEN:
26.44%
DLB:
-62.19%
QGEN:
-92.14%
DLB:
-23.96%
QGEN:
-21.11%
Fundamentals
DLB:
$7.17B
QGEN:
$9.75B
DLB:
$2.64
QGEN:
$0.43
DLB:
28.41
QGEN:
104.65
DLB:
2.08
QGEN:
1.01
DLB:
5.43
QGEN:
4.87
DLB:
2.79
QGEN:
2.82
DLB:
$1.32B
QGEN:
$2.00B
DLB:
$1.17B
QGEN:
$1.00B
DLB:
$121.80M
QGEN:
$372.10M
Returns By Period
In the year-to-date period, DLB achieves a -4.14% return, which is significantly lower than QGEN's 1.28% return. Over the past 10 years, DLB has outperformed QGEN with an annualized return of 7.86%, while QGEN has yielded a comparatively lower 6.29% annualized return.
DLB
-4.14%
-2.88%
-4.01%
-4.79%
0.00%
5.50%
7.86%
QGEN
1.28%
5.57%
3.85%
5.77%
-0.67%
0.56%
6.29%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
DLB vs. QGEN — Risk-Adjusted Performance Rank
DLB
QGEN
DLB vs. QGEN - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Dolby Laboratories, Inc. (DLB) and Qiagen N.V. (QGEN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
DLB vs. QGEN - Dividend Comparison
DLB's dividend yield for the trailing twelve months is around 1.74%, less than QGEN's 2.79% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DLB Dolby Laboratories, Inc. | 1.74% | 1.57% | 1.29% | 1.45% | 0.96% | 0.91% | 1.15% | 1.08% | 0.94% | 1.11% | 1.25% | 0.23% |
QGEN Qiagen N.V. | 2.79% | 2.88% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.42% | 0.00% | 0.00% | 0.00% |
Drawdowns
DLB vs. QGEN - Drawdown Comparison
The maximum DLB drawdown since its inception was -62.19%, smaller than the maximum QGEN drawdown of -92.14%. Use the drawdown chart below to compare losses from any high point for DLB and QGEN.
Loading data...
Volatility
DLB vs. QGEN - Volatility Comparison
The current volatility for Dolby Laboratories, Inc. (DLB) is 5.45%, while Qiagen N.V. (QGEN) has a volatility of 7.74%. This indicates that DLB experiences smaller price fluctuations and is considered to be less risky than QGEN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
DLB vs. QGEN - Financials Comparison
This section allows you to compare key financial metrics between Dolby Laboratories, Inc. and Qiagen N.V.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
DLB vs. QGEN - Profitability Comparison
DLB - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Dolby Laboratories, Inc. reported a gross profit of 333.72M and revenue of 369.56M. Therefore, the gross margin over that period was 90.3%.
QGEN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Qiagen N.V. reported a gross profit of 308.68M and revenue of 483.46M. Therefore, the gross margin over that period was 63.9%.
DLB - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Dolby Laboratories, Inc. reported an operating income of 111.97M and revenue of 369.56M, resulting in an operating margin of 30.3%.
QGEN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Qiagen N.V. reported an operating income of 115.35M and revenue of 483.46M, resulting in an operating margin of 23.9%.
DLB - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Dolby Laboratories, Inc. reported a net income of 91.79M and revenue of 369.56M, resulting in a net margin of 24.8%.
QGEN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Qiagen N.V. reported a net income of 90.76M and revenue of 483.46M, resulting in a net margin of 18.8%.